Managing Hypertension in Patients With Stroke Are You Prepared for Labetalol Infusion?

Harrington, Cindy
June 2003
Critical Care Nurse;Jun2003, Vol. 23 Issue 3, p30
Academic Journal
Focuses on nursing considerations for the management of hypertension, including administration of labetalol, in patients with acute ischemic stroke treated with alteplase. Discussion on the relationship of cerebral blood flow, blood pressure and stroke; Mechanisms of hypertension in acute ischemic stroke.


Related Articles

  • Hypertension and stroke.  // Formulary;Nov2004, Vol. 39 Issue 11, p560 

    Presents the approval status of drugs proposed for the treatment of hypertension and stroke. Aliskiren; Clevidipine; Lercanidipine; Nebivolol; Citicoline.

  • Recent Advances in the Treatment of Hypertensive Emergencies. Smithburger, Pamela L.; Kane-Gill, Sandra L.; Nestor, Breanne L.; SeyberT, Amy L. // Critical Care Nurse;Oct2010, Vol. 30 Issue 5, p24 

    The article discusses hypertension emergencies and its treatment. It states that the clinical findings of target organ damage include hypertensive encephalopathy, intracranial hemorrhage, unstable angina, acute myocardial infarction, acute left ventricular failure with pulmonary edema, aortic...

  • Eprosartan worth it in hypertension + cerebrovascular disease.  // PharmacoEconomics & Outcomes News;11/17/2007, Issue 541, p8 

    The article reports on the results of a cost utility study which showed that eprosartan should be considered a cost-effective treatment option for hypertension in patients with cerebrovascular disease in Europe. Based on the study, eprosartan would prevent approximately 58 secondary...

  • Short-acting nifedipine increases stroke risk in elderly hypertensives.  // Reactions Weekly;9/10/2011, Issue 1368, p1 

    The article discusses a research study on the association between short-acting nifedipine and risk of stroke in elderly hypertensive patients. It references a study by S. Y. Jung and colleagues, published in the August 17, 2011 issue of the journal "Neurology." Findings of the study, which was...

  • Guancydine: A New Antihypertensive Agent. Clark, Dwight W.; Goldberg, Leon I. // Annals of Internal Medicine;Apr72, Vol. 76 Issue 4, p579 

    Discusses a study which evaluated the efficacy and acceptability of guancydine as part of the therapeutic program for patients with hypertension. Dosage regimens administered to the study population; Clinical presentation of the patients; Adverse effects of guancydine.

  • Hypertension Drug Debuts.  // Chain Drug Review;2/27/2012, Vol. 34 Issue 4, p44 

    The article offers information on Edarbyclor, an antihypertensive drug for the treatment of hypertension in adults of the U.S.

  • Resistant hypertension: What to do after trying `the usual'. Kaplan, Norman M. // Geriatrics;May95, Vol. 50 Issue 5, p24 

    Discusses the management of resistant hypertension. Incidence of resistant hypertension; Factors that cause poor response to antihypertensive drug therapy; Physiologic causes of resistant hypertension; Ways to improve drug compliance.

  • Treating hypertension: the evidence from clinical trials. Simon, Joel A. // BMJ: British Medical Journal (International Edition);8/24/96, Vol. 313 Issue 7055, p437 

    Editorial. Discusses the hypertensive treatment modalities. Evolving guidelines in treating hypertension; Analyses of the clinical trials of antihypertensive drugs; Parameters of drug effectiveness.

  • Candesartan Cilexetil: An Update of its Use in Essential Hypertension. Easthope, S.E.; Jarvis, B. // Drugs;2002, Vol. 62 Issue 8, p1253 

    Candesartan cilexetil is converted to the angiotensin II receptor antagonist candesartan during absorption from the gastrointestinal tract. The selective and competitive binding of candesartan to the angiotensin II type 1 (AT) receptor prevents binding of angiotensin II, a key mediator in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics